Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Compugen (CGEN) Research & Development (2016 - 2025)

Compugen's Research & Development history spans 17 years, with the latest figure at $5.5 million for Q4 2025.

  • On a quarterly basis, Research & Development fell 6.23% to $5.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $22.8 million, a 8.27% decrease, with the full-year FY2025 number at $22.8 million, down 8.27% from a year prior.
  • Research & Development hit $5.5 million in Q4 2025 for Compugen, down from $5.8 million in the prior quarter.
  • Over the last five years, Research & Development for CGEN hit a ceiling of $10.9 million in Q4 2023 and a floor of $5.5 million in Q4 2025.
  • Historically, Research & Development has averaged $7.1 million across 5 years, with a median of $6.8 million in 2021.
  • Biggest five-year swings in Research & Development: soared 58.63% in 2021 and later plummeted 45.91% in 2024.
  • Tracing CGEN's Research & Development over 5 years: stood at $5.8 million in 2021, then rose by 25.4% to $7.3 million in 2022, then soared by 49.15% to $10.9 million in 2023, then plummeted by 45.91% to $5.9 million in 2024, then fell by 6.23% to $5.5 million in 2025.
  • Business Quant data shows Research & Development for CGEN at $5.5 million in Q4 2025, $5.8 million in Q3 2025, and $5.6 million in Q2 2025.